Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, February 23, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilance
Scientific Writing
Other
About us
Search
LATEST ARTICLES
Clinical Data Management
Parts of a clinical trial protocol and Clinical Data Management (CDM) prospective to review
admin
-
December 9, 2019
0
Latest Pharma-News
Only treatment approved in the US for relapsed or refractory hairy cell leukemia Approved by FDA at ASH 2019
admin
-
December 9, 2019
0
Latest Pharma-News
Amgen’s AVSOLA™ received FDA approval for AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab)for the treatment of Rheumatoid Arthritis, Crohn’s Disease, Ulcerative Colitis,...
admin
-
December 9, 2019
0
Latest Pharma-News
ViiV Healthcare submits New Drug Application to the US FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults
admin
-
December 9, 2019
0
Latest Pharma-News
FDA authorizes marketing of diagnostic test cobas vivoDx that uses novel technology to detect Methicillin-resistant Staphylococcus aureus (MRSA) bacteria
admin
-
December 9, 2019
0
Latest Pharma-News
First investigational drug therapy for liver disease non alcoholic steatohepatitis (NASH) awaiting FDA approval
admin
-
December 9, 2019
0
Latest Pharma-News
Data fron XOSPATA® in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual Meeting
admin
-
December 9, 2019
0
Latest Pharma-News
First generics of Gilenya approved by FDA for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients
admin
-
December 6, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Alecto’s investigational therapeutic AL001, for the treatment of patients with...
admin
-
December 6, 2019
0
Latest Pharma-News
U.S. FDA approved BMS Breakthrough Therapy Designation for ORENCIA® (abatacept) just to help in Preventing Acute Graft-Versus-Host Disease, a Potentially Life-Threatening Complication...
admin
-
December 6, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) approved Investigational New Drug (IND) application for Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy
admin
-
December 5, 2019
0
Latest Pharma-News
Ardelyx’s kidney disease drug succeeded in regulating elevated blood phosphate levels in patients with chronic kidney disease (CKD)
admin
-
December 5, 2019
0
1
...
149
150
151
...
156
Page 150 of 156
Other
What is Decentralized clinical trials?:Benefits and challenges of implementing DCT
September 23, 2024
Navigating the Job Interview: How to Answer the Question, “Why Are You Changing Jobs?”
September 16, 2023
Big Data Analytics: New Possibilities In The Pharmaceutical Industry
November 19, 2021
Causes, Symptoms And Treatment Of Mesothelioma
October 4, 2021
Load more